This page includes the latest FDA filings for Mobius Therapeutics L L C. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Registration Number | 3013777332 |
FEI Number | 3013777332 |
Name | MOBIUS THERAPEUTICS LLC |
Owner & Operator | Mobius Therapeutics LLC |
Contact Address | 1000 Executive Parkway Drive Suite 224 Saint Louis MO 63141 US |
Official Correspondent |
|
Registration Status | 1 |
Initial Importer | Y |
Registration Expiration | 2020-04-25 |
Registration Address | 1000 Executive Parkway Drive Suite 224 Saint Louis, MO 63141 US |
Device Company | Device | Date |
---|---|---|
Mobius Therapeutics LLC | Prescription Medication | 2022-12-17 |
Mobius Therapeutics LLC | Prescription Medication | 2021-05-01 |
Mobius Therapeutics LLC | Prescription Medication | 2020-08-22 |
Mobius Therapeutics LLC | Prescription Medication | 2018-01-05 |
Mobius Therapeutics LLC | Mitosol | 2012-02-08 |
NCAGE Code | 5B1B9 | MOBIUS THERAPEUTICS, LLC |
CAGE Code | 5B1B9 | MOBIUS THERAPEUTICS, LLC |
S.A.M. Registration | 5B1B9 [805642118] | MOBIUS THERAPEUTICS, LLC |
SEC | 0001407296 | Mobius Therapeutics LLC of DELAWARE |